lobbying_activities: 1185200

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1185200	6d36a7fd-6527-411d-973d-5d4d77fe3f9a	Q4	INDEPENDENT PHARMACY COOPERATIVE	313098	INDEPENDENT PHARMACY COOPERATIVE	2011	fourth_quarter	PHA	CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 274 The Medication Management Empowerment Act of 2011. All provisions S. 1002 Prohibit Theft of Medical Products 2011. All provisions. Potential prescription drug track-and-trace legislation. CMS Medicare Part B diabetic supply audits Region D. Concerns with scope and requirements of audit.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE		10000	0	0	2012-01-13T13:51:24-05:00